AstraZeneca: E-Mobility for a Greener Future

BUSINESS: 367 PRACTICES
At AstraZeneca, to respond effectively to a changing world and increased disease burden, we continuously invest in one of the most powerful and efficient production lines in the pharmaceutical industry. We work hard to deliver life-changing medicines and treatments to patients around the world.
We continue to push the boundaries of science to deliver innovative medicines and therapies that prevent, treat and cure some of the world's most important health challenges, including cancer, diabetes, heart, kidney and respiratory diseases. At AstraZeneca, innovation is a concept intertwined with growth. It is the driving force behind our vision to improve the lives of thousands of people by bringing them innovative treatments. At the same time, we ensure that these medicines reach the patients who need them, in a way that benefits society and our planet.
The initiative aimed to reduce CO₂ emissions from daily commuting, promote environmental awareness within the company (with full voluntary participation of employees), and showcase the role of businesses in the country’s green transition. It is part of the “We Protect the Environment… with Actions” strategy and aligns with AstraZeneca’s global Ambition Zero Carbon goal of full decarbonization by 2045 and a carbon-negative footprint by 2030.
Employees, healthcare professionals, business community, general public.
Launched in 2019 under “We Protect the Environment… with Actions”. Full fleet transition completed in 2022–2023. Ongoing application.
AstraZeneca Greece completed the full transition of its corporate fleet to zero-emission electric vehicles. A total of 230 cars were replaced with EVs, 42 chargers were installed at the headquarters in Marousi, and 100 home chargers were provided for employees’ private use.
Selected chargers were 22kW with WiFi-enabled reporting, with costs of €1,800 + VAT per installation covered by the company’s corporate card. Employees opting for other models benefited from preferential pricing.
This project represents the first large-scale full transition to e-mobility in the Greek pharmaceutical sector. The creation of a supportive framework (corporate and home charging stations), immediate application, and the integration of sustainability into corporate culture highlight the innovative and model nature of the initiative.
Awareness campaign:
Greece – Headquarters (Marousi) and employees’ households.
Partnership with charging infrastructure providers and communication agencies for the awareness campaign.
All employees actively participated by adopting EVs and installing chargers at home. Internal training and engagement activities strengthened environmental responsibility.